WO2007063556A3 - An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs - Google Patents

An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs Download PDF

Info

Publication number
WO2007063556A3
WO2007063556A3 PCT/IN2007/000019 IN2007000019W WO2007063556A3 WO 2007063556 A3 WO2007063556 A3 WO 2007063556A3 IN 2007000019 W IN2007000019 W IN 2007000019W WO 2007063556 A3 WO2007063556 A3 WO 2007063556A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
improved
industrial process
alfuzosin hydrochloride
novel polymorphs
Prior art date
Application number
PCT/IN2007/000019
Other languages
French (fr)
Other versions
WO2007063556A2 (en
Inventor
Reddy Manne Satyanarayana
Kumar Muppa Kishore
Reddy Bairy Kondal
Mummadi Venkatesh
Original Assignee
Msn Lab Ltd
Reddy Manne Satyanarayana
Kumar Muppa Kishore
Reddy Bairy Kondal
Mummadi Venkatesh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msn Lab Ltd, Reddy Manne Satyanarayana, Kumar Muppa Kishore, Reddy Bairy Kondal, Mummadi Venkatesh filed Critical Msn Lab Ltd
Publication of WO2007063556A2 publication Critical patent/WO2007063556A2/en
Publication of WO2007063556A3 publication Critical patent/WO2007063556A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

An improved and industrial process for the preparation of Alfuzosin Hydrochloride and its novel polymorphs (Formula (I)).
PCT/IN2007/000019 2006-12-07 2007-01-19 An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs WO2007063556A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2270CH2006 2006-12-07
IN2270/CHE/2006 2006-12-07

Publications (2)

Publication Number Publication Date
WO2007063556A2 WO2007063556A2 (en) 2007-06-07
WO2007063556A3 true WO2007063556A3 (en) 2008-07-31

Family

ID=38092663

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000019 WO2007063556A2 (en) 2006-12-07 2007-01-19 An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs

Country Status (1)

Country Link
WO (1) WO2007063556A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106632280A (en) * 2016-11-24 2017-05-10 辽宁可济药业有限公司 Method for preparing alfuzosin hydrochloride

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1390760B1 (en) * 2008-07-21 2011-09-23 Lundbeck Pharmaceuticals Italy Spa METHOD OF PREPARATION OF ALPHUZOSIN CHORIDIDATE ANHYDROUS
CN114591273B (en) * 2022-03-31 2023-07-21 邦恩泰(山东)生物医药科技集团股份有限公司 Synthesis method and application of N-methyl-N' -tetrahydrofuranyl propylenediamine oxalate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1616438A (en) * 2004-09-24 2005-05-18 鲁南制药股份有限公司 Process for preparing alfuzosin hydrochloride
WO2006030449A1 (en) * 2004-09-16 2006-03-23 Hetero Drugs Limited Crystalline alfuzosin base
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006030449A1 (en) * 2004-09-16 2006-03-23 Hetero Drugs Limited Crystalline alfuzosin base
CN1616438A (en) * 2004-09-24 2005-05-18 鲁南制药股份有限公司 Process for preparing alfuzosin hydrochloride
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106632280A (en) * 2016-11-24 2017-05-10 辽宁可济药业有限公司 Method for preparing alfuzosin hydrochloride

Also Published As

Publication number Publication date
WO2007063556A2 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
WO2005108358A3 (en) Pyrrolidine derivatives useful as bace inhibitors
ZA200900551B (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2006092213A8 (en) Pyrazolylcarboxanilides
WO2009156462A3 (en) Organic compounds
WO2009067674A3 (en) Polymorphs of sunitinib base and processes for preparation thereof
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
IL196527A (en) Substituted heteroaryl derivatives, processes for their manufacture and uses thereof
WO2006034093A3 (en) 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
HK1115631A1 (en) Process for the identification of novel enzyme interacting compounds
WO2008083248A3 (en) Cyclopamine analogs
WO2009079008A8 (en) Benzopyrans and analogs as rho kinase inhibitors
WO2010062715A3 (en) Polymorphs of dasatinib and process for preparation thereof
WO2007010555A3 (en) Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
WO2008021342A3 (en) Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone )
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
WO2008058118A3 (en) Preparation of montelukast and its salts
IL192231A0 (en) An improved process for the preparation of armodafinil
WO2007062314A3 (en) Heterocyclic cetp inhibitors
WO2006134499A3 (en) 2-(1h-indolylsulfanyl)-aryl amine derivatives
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2009000533A8 (en) Novel herbicides
WO2007117760A3 (en) Preparation of gemcitabine
WO2008075205A3 (en) Improved process for the preparation of voriconazole
IL184715A0 (en) Process for the preparation of intermediates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07706186

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)